Community pharmacist interventions in a capitated pharmacy benefit contract

被引:21
作者
Knapp, KK [1 ]
Katzman, H
Hambright, JS
Albrant, DH
机构
[1] Univ Pacific, Sch Pharm, Stockton, CA 95211 USA
[2] Integrated Hlth Concepts, Walnut Creek, CA USA
[3] Pharmacists Managed Care, Sacramento, CA USA
[4] Pharm Dynam, Arlington, VA USA
关键词
benchmarking; capitation; drugs; economics; errors; medication; interventions; managed rare systems; patient information; pharmacists; community; pharmacy; prescriptions;
D O I
10.1093/ajhp/55.11.1141
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Documented interventions associated with processing prescriptions in a managed care environment were analyzed, and a benchmark for interventions was proposed. A retrospective analysis of documented interventions by 31 pharmacies contracted by a managed care organization to serve 22,000 Medi-Cal patients was undertaken. An intervention consisted of identifying any problem related to a prescription, taking action, and recording the problem, action, and outcome on a form. Problems were categorized as drug selection issues, clinical issues, errors in prescription writing, and patient education issues. A similar process was followed for describing actions and outcomes. The data were used as an indicator of prescription-related problems in contemporary pharmacies in a managed care environment; data from another study were used as an indicator of "ideal" pharmacist performance in detecting and resolving problems. The estimated intervention rate when pharmacists meeting ideal performance expectations worked in a managed care environment was set as a benchmark. The economic impact of drug selection interventions was determined as well. Data were retrieved and compiled from 595 (93.4%) of 637 interventions performed in 1995, when 93,483 contract-related prescriptions were processed by the 31 pharmacies. Fifty percent of problems related to drug selection issues. The most frequent action was contacting the prescriber (56.1%). The overall intervention rate was 0.7% (range, 0-4.1%). It was estimated that 4% of prescriptions would require an intervention; two pharmacies met this level. Interventions resulting in prescription change realized an average decrease in cost of 65.8%. Community pharmacies under contract with a managed care organization intervened on 0.7% of prescriptions, but the rate of intervention across pharmacies was inconsistent, ranging from 0% to 4.1%; a benchmark of 4% would be reasonable.
引用
收藏
页码:1141 / 1145
页数:5
相关论文
共 16 条
[1]   RELATIONSHIP BETWEEN MEDICATION ERRORS AND ADVERSE DRUG EVENTS [J].
BATES, DW ;
BOYLE, DL ;
VLIET, MVV ;
SCHNEIDER, J ;
LEAPE, L .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1995, 10 (04) :199-205
[2]  
Bates DW, 1996, AM J HEALTH-SYST PH, V53, P747
[3]   PHARMACIST-MANAGED MEDICATION REVIEW IN A MANAGED CARE SYSTEM [J].
BORGSDORF, LR ;
MIANO, JS ;
KNAPP, KK .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (06) :772-777
[4]  
CARDINA V, 1995, DRUG TOPICS RED BOOK
[5]  
*CIB, 1996, CIB PHARM BEN REP FA
[6]  
FINCHAM J, 1996, NARD J, V118, P29
[7]  
FINCHAM J, 1995, NARD J, V117, P29
[8]  
*GEN ACC OFF, 1995, PRESCR DRUGS ELD
[9]  
HEADDEN S, 1996, US NEWS WORLD R 0826, P46
[10]   DRUG-RELATED MORBIDITY AND MORTALITY - A COST-OF-ILLNESS MODEL [J].
JOHNSON, JA ;
BOOTMAN, JL .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (18) :1949-1956